PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC13138602::ACT044659

Phoenixin-14 amide

Evidence text

Paper-level observation

PNX-14 treatment at 2.5 nmol significantly improved primordial follicle numbers (24.2 ± 2.8%; P < 0.05 vs PCOS), whereas higher doses showed no further improvement (Fig. 3A).
textConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
Other
Measure
other
Comparator
=
Raw observation
24.2 ± 2.8%
Normalized measurement
=24.2%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
DVQPPGLKVWSDPFNH
Standardization
ready simple

Source publication

Phoenixin-14 ameliorates ovarian morphology in a DHEA-induced rat model of PCOS

Reproduction & Fertility · 2026

DOI 10.1530/RAF-25-0142 PMC13138602
Parent mention

Related peptide identities

PEPDIA-PLP-000501

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.